|
|
||||||||
Ann Thorac Surg 2000;70:106-110
© 2000 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada
Address reprint requests to Dr Black, Department of Pediatric Cardiac Surgery, The Lucile Packard Childrens Hospital, Stanford University School of Medicine, Stanford, CA 94305-5407
e-mail: michael.black{at}stanford.edu
| Abstract |
|---|
|
|
|---|
Methods. We performed a retrospective analysis of hospital and echocardiographic data of eight children who underwent a septal obliteration technique (SOT) as part of their correction of mVSDs (with and without coarctation of the aorta).
Results. Eight children with a mean age of 10.5 months (range 1.5 to 36 months), and weight of 6.2 kg (range 2.1 to 13.5 kg), respectively, underwent correction of mVSDs. All had a single, large, perimembranous defect, additional VSDs within the muscular trebecular septum (juxtaposed to the moderator band), and apical mVSDs. All VSDs were repaired via the right atrium, with avoidance of either a right or left ventriculotomy. The posterior and apical defects were excluded from the right ventricular cavity with a pericardial patch (SOT). The follow-up period remains limited to a mean of 20.9 months (8 to 39 months). Two children repaired with SOT had previous pulmonary artery bands (neonatal coarctation repair). All children were successfully discharged home with a mean postoperative Qp:Qs of 1.09:1. One pacemaker was required, but this child has since reverted back to normal sinus rythm.
Conclusions. Our initial experience using the SOT in the treatment of apical VSDs as a component of isolated mVSDs has been rewarding. All children are currently alive, in normal sinus rhythm, and have no residual significant left-to-right shunts.
| Introduction |
|---|
|
|
|---|
In this report, we describe our early experience with the septal obliteration technique used for the repair of multiple muscular VSDs. In addition, we highlight the benefits of cardioscopy in the diagnosis and repair of such complex congenital heart defects.
| Material and methods |
|---|
|
|
|---|
Operative technique
After standard induction of anesthesia and placement of monitoring lines, the patient was placed on cardiopulmonary bypass by cannulating the ascending aorta and both vena cavae (the superior vena cava is cannulated via the right atrial appendage in order to prevent possible iatrogenic caval stenosis). A left ventricular vent is placed via the right superior pulmonary vein.
The repair of aortic arch abnormalities with the avoidance of circulatory arrest has been optimized with a specially designed "selective" catheter. The technique has been detailed previously [2]. After the establishment of total cardiopulmonary bypass and the administration of antegrade blood cardioplegia, the caval snares are tightened. A right atriotomy is fashioned, and the atrial communication is located. If the atrial septum is intact, an atrial septotomy is created through the fossa ovalis.
Without cardioscopy
Via the tricuspid valve, the larger VSDs can usually be located. Via the perimembranous VSD and the atrial septal communication, gentle probing of the muscular septum is initiated to corroborate the preoperative studies. Outlet VSDs frequently require a pulmonary arteriotomy in order to optimize visualization as well as suture placement. The larger perimembranous defects are obliterated in the standard fashion first (interrupted plegetted braided polyester sutures), followed by closure of the midmuscular defects. The latter defects usually can be found directly beneath the moderator band. No child has required division of this muscular structure; instead, retraction usually allows for the placement of a single patch (even though it is common for the preoperative studies to demonstrate two jets of blood flow, above and below this muscular bar). The conduction system is in danger of either temporary or permanent damage passing between both patches.
Once the general location of the multiple apical lesions is identified, an appropriate sized autologous pericardial patch pretreated in glutaraldehyde is positioned over the central region of the defects. Occasionally, several small trabeculae are transected in order for the patch to be placed as "flush" as possible with the remaining ventricular septum. Depending of the location of the defects, the patch may need to be fixed anteriorly, incorporating a portion of even the anterior right ventricle. Pledgetted sutures are strategically placed circumferentially in order to secure the patch and prevent diminution of the right ventricular cavity or inflow occlusion across the inlet septum. If chords to the tricuspid valve were transected, they are resecured at this time. The tricuspid valve is tested for functional competence by insufflation of saline into the right ventricle. This latter maneuver is useful for verifying obliteration of most of the shunt lesions, by observing how much, if any, saline returns from the left ventricular vent. The atrial septal defect is closed. The vent should now have a continuous column of blood without significant retained air. The left side of the heart is carefully deaired followed by removal of the aortic cross-clamp and systemic rewarming. Pacing wires are placed and tested regardless of the rhythm (even if normal sinus). If several ventricular patches are placed, a period of septal akinesis or even dyskinesis is common; therefore, the patient is maintained on inotropes for 48 hours until ventricular function returns to "normal."
With cardioscopy
The techniques are similar to that described above except that via the large perimembranous VSD or the aortic root, the left side of the ventricular septum is inspected (Fig 1a). A single large defect in the apical region can sometimes be identified, permitting novel closure strategies: (1) the defect can be illuminated (Fig 1A) and approached with the SOT from the right (Fig 1B) (n = 2); or (2) a silk suture can be passed, demonstrating the extreme upper and lower margins of the defect (n = 2).
|
|
| Results |
|---|
|
|
|---|
|
| Comment |
|---|
|
|
|---|
While the intraoperative deployment of a trans-septal occluding device (limited percutaneous deployment by the caliber of the femoral vessels) has been reported and remains appealing, its popularity has been limited to lack of expertise and availability [3]. In the original 10 children reported, device deployment was unacceptable due to an "inadequate septal rim" (n = 1). There were early (n = 3) deaths secondary to poor ventricular function. In the six survivors, 50% were found to have a Qp:Qs greater than 2.0:1 after device closure. There was one late death in this latter subgroup. Therefore, the overall mortality rate was 44%. However, with technological improvement and better patient selection, improved results can be anticipated.
As such, we have found the septal obliteration technique rewarding in tackling multiple apical and posterior muscular VSDs. The technique, at least in theory, remains similar to that proposed by the interventional cardiologists in favor of device closure. The obliteration of the passage of blood across the septum is accomplished without the closure of each and every defect. A further advantage of the one-stage surgical repair remains the ability for simultaneous closure of other large (perimembranous and midmuscular) defects.
Muscular defects of the ventricular septum may be single or multiple, with four or more communications giving the septum a "Swiss cheese" appearance. Trebecular VSDs have been traditionally divided into high, mid, and low or apical VSDs. Most VSDs are in the area of the membranous portion of the ventricular septum in close relationship to the aortic or tricuspid valves. However, muscular VSDs are often located behind the hypertrophied trabecular carnae of papillary muscles. The management of multiple muscular defects in the lower part of the ventricular septum has been less than satisfactory. This may be due to the combination of a limited accessibility and difficulty in identification. We have recently employed the cardioscope for identification of defects from the left side of the ventricular septum via the aortic root when exposure was limited via the right atrium. Although preliminary, we feel that this technique will have increased future applications by allowing identification and closure via the left side or by the illumination of the area that requires SOT application from the right side.
Although various surgical approaches have been suggested as being superior (ie, right atriotomy, right or left ventriculotomy) and the "sandwich technique" suggested by Kirklin and utilized by Breckenridge and colleagues, the myriad of techniques is testimony to the lack of superiority of any one technique [49].
Multiple VSDs have been reported in 2% to 18% of the total number of patients with VSDs [6]. Incomplete or insecure closure remains a significant reason for the high surgical mortality of multiple VSDs [4, 1012]. In fact, death was directly related to residual VSDs in over one-half of the patients, with associated pulmonary hypertension and right ventricular failure [13]. The unsatisfactory results obtained with the two-stage approach, and the concomitant improved reported mortality for primary repair, stimulated us to look for alternative methods to improve the localization and obliteration of multiple VSDs during the one-staged repair [14].
McNicholas and associates reported that the total operative mortality from the time of presentation, with or without operation, for patients with multiple VSDs was 20% as opposed to 4% for children with single VSDs [15]. Fox and associates reported similar results in infants with intractable heart failure from multiple VSDs treated by pulmonary banding (mortality 8.3%) and subsequent debanding and multiple VSD closure (mortality 27%). Where operation for multiple VSDs was delayed beyond 1 year of age, primary total correction was performed with a mortality of 18% [10].
In the present era, Serraf and associates provide further evidence that low trabecular VSDs remains a significant risk factor for morbidity (ie, death and residual VSDs) (p < 0.01). Although their early mortality rate remained low (7.7%), the reoperative mortality rate for residual defects remained high (33%) [13].
We suggest that pulmonary arterial banding in infancy should be reserved for those children with contraindications to anticoagulation and thus cardiopulmonary bypass, complex associated congenital lesions that may in themselves require a period of palliation or a "watering can" type of spongiform ventricle. Intracardiac repair can be delayed to about 2 years of age [15].
Our initial experience using the septal obliteration technique in the treatment of apical VSDs as a component of isolated multiple VSDs has been rewarding. All children are currently alive, in normal sinus rhythm, and have no residual significant left-to-right shunts. We have a final word of caution regarding the intraoperative echocardiographic interpretation of a significant residual postrepair shunts: if in doubt, determine the postrepair intraoperative Qp:Qs. Experience has demonstrated the passage of blood remains limited by the SOT patch into the "blind-ending" apical neochamber (Fig 1C).
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Murakami, N. Yoshimura, H. Takahashi, H. Matsuhisa, M. Yoshida, Y. Oshima, T. Misaki, and M. Yamaguchi Closure of multiple ventricular septal defects by the felt sandwich technique: Further analysis of 36 patients. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 278 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Myhre, B. W. Duncan, R. B. B. Mee, R. Joshi, S. G. Seshadri, O. Herrera-Verdugo, and G. L. Rosenthal Apical right ventriculotomy for closure of apical ventricular septal defects Ann. Thorac. Surg., July 1, 2004; 78(1): 204 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sivakumar, S. R. Anil, S. G. Rao, K. Shivaprakash, and R. K. Kumar Closure of muscular ventricular septal defects guided by en face reconstruction and pictorial representation Ann. Thorac. Surg., July 1, 2003; 76(1): 158 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Van Praagh, J. E. Mayer Jr, N. B. Berman, M. F. Flanagan, T. Geva, and R. Van Praagh Apical ventricular septal defects: follow-up concerning anatomic and surgical considerations Ann. Thorac. Surg., January 1, 2002; 73(1): 48 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Kanter Invited commentary Ann. Thorac. Surg., January 1, 2002; 73(1): 56 - 57. [Full Text] [PDF] |
||||
![]() |
C. Wong, K. Mason, J.R. L. Hamilton, A. Hasan, and R. M. Freedom Intraoperative location of muscular ventricular septal defects Ann. Thorac. Surg., November 1, 2001; 72(5): 1800 - 1800. [Full Text] [PDF] |
||||
![]() |
M. D. Black, V. Shukla, V. Rao, J. F. Smallhorn, and R. M. Freedom Intraoperative location of muscular ventricular septal defects: Reply Ann. Thorac. Surg., November 1, 2001; 72(5): 1800 - 1801. [Full Text] [PDF] |
||||
![]() |
M. D. Black, N. Pike, M. Koransky, M. Humel, P. J. McCarthy, R. Smith, G. M. Boltz, V. Wellis, S. Uezono, and G. B. Hammer Innovations and Future Directions in Pediatric Cardiac Anesthesia and Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 113 - 116. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |